http://www.physorg.com/ en-us Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine. Researchers at the University of Pittsburgh School of Medicine and the National Cancer Institute (NCI), part of the National Institutes of Health, may be hot on the heels of a Holy Grail of cancer therapy: They have found a way to not only protect healthy tissue from the toxic effects of radiation treatment, but also increase tumor death. The findings appear today in Science Translational Medicine. http://www.physorg.com/news175355067.html Medicine & Health Wed, 21 Oct 2009 15:00:03 EST news175355067 Scientists have created a viable technology to improve the detection of leukemia cells in bone marrow. http://www.physorg.com/news174058065.html Medicine & Health Tue, 06 Oct 2009 16:40:01 EST news174058065 A key compound resupplies bone marrow with fast-acting stem cells that can more quickly rekindle blood cell production, according to a study published online today in the journal Blood. While the study was in mice, in the study authors say it has the potential to increase survival among patients with life-threatening blood cell shortages. http://www.physorg.com/news171122279.html Medicine & Health Wed, 02 Sep 2009 15:10:02 EST news171122279 A study of 7,689 admissions from 178 adult intensive care units in England, Wales and Northern Ireland has revealed the factors associated with a higher mortality rate in haematological malignancy. Researchers writing in BioMed Central's open access journal Critical Care found that certain factors have a significant impact on the risk of death. http://www.physorg.com/news170361730.html Medicine & Health Mon, 24 Aug 2009 20:50:01 EST news170361730 A UCSF study for the treatment of heart failure after heart attack found that the extract derived from bone marrow cells is as effective as therapy using bone marrow stem cells for improving cardiac function, decreasing the formation of scar tissue and improving cardiac pumping capacity after heart attack. http://www.physorg.com/news165512730.html Medicine & Health Mon, 29 Jun 2009 17:00:01 EST news165512730 A main reason why viruses such as HIV or hepatitis C persist despite a vigorous initial immune response is exhaustion. The T cells, or white blood cells, fighting a chronic infection eventually wear out. http://www.physorg.com/news161454772.html Medicine & Health Wed, 13 May 2009 17:33:37 EST news161454772 Great interest has been aroused in the identification and isolation of liver stem cells from bone marrow cells. Several subsets of bone marrow cells have been found to have the potential to differentiate into hepatocytes, however, sorting based on immunological methods is difficult because of the complicated surface markers of the stem cells; furthermore, no report of successful passage has been published. http://www.physorg.com/news159028051.html Medicine & Health Wed, 15 Apr 2009 15:28:06 EST news159028051 Bone marrow transplant (BMT) researchers at The Medical College of Wisconsin Cancer Center in Milwaukee may have found a mechanism that could preserve the leukemia-killing effects of a transplant graft, while limiting the damage donor immune cells might do to the recipient host's vital organs. http://www.physorg.com/news153595750.html Medicine & Health Wed, 11 Feb 2009 17:29:48 EST news153595750 Transplanting cells that replenish blood vessels can also restore nerve function in an animal model of diabetic neuropathy, Emory researchers have found. The results are described online this week in the journal Circulation. http://www.physorg.com/news152977005.html Medicine & Health Wed, 04 Feb 2009 13:37:29 EST news152977005 (PhysOrg.com) -- Artificial bone marrow that can continuously make red and white blood cells has been created in a University of Michigan lab. http://www.physorg.com/news149189072.html Biology Mon, 22 Dec 2008 17:24:32 EST news149189072 Stem cells derived from bone marrow may serve as a novel therapeutic option to treat a disease called epidermolysis bullosa (EB), a disorder characterized by extraordinarily fragile skin, according to a study prepublished online in Blood, the official journal of the American Society of Hematology. http://www.physorg.com/news147618795.html Medicine & Health Thu, 04 Dec 2008 13:13:15 EST news147618795 A new University of Michigan study in mice suggests that a drug recently approved to fight cancer tumors is also able to reduce the effects of graft-versus-host disease, a common and sometimes fatal complication for people who have had bone marrow transplants. http://www.physorg.com/news134925182.html Medicine & Health Thu, 10 Jul 2008 16:13:02 EST news134925182